Found 36 results
Author Title [ Type(Asc)] Year
Filters: Author is Hill, Heather  [Clear All Filters]
Journal Article
D. I. Bernstein, Edwards, K. M., Dekker, C. L., Belshe, R., Talbot, H. K. B., Graham, I. L., Noah, D. L., He, F., and Hill, H., “Effects of adjuvants on the safety and immunogenicity of an avian influenza H5N1 vaccine in adults.”, J Infect Dis, vol. 197, no. 5, pp. 667-75, 2008.
L. A. Jackson, Campbell, J. D., Frey, S. E., Edwards, K. M., Keitel, W. A., Kotloff, K. L., Berry, A. A., Graham, I., Atmar, R. L., C Creech, B., Thomsen, I. P., Patel, S. M., Gutierrez, A. F., Anderson, E. L., Sahly, H. M. El, Hill, H., Noah, D. L., and Bellamy, A. R., “Effect of Varying Doses of a Monovalent H7N9 Influenza Vaccine With and Without AS03 and MF59 Adjuvants on Immune Response: A Randomized Clinical Trial.”, JAMA, vol. 314, no. 3, pp. 237-46, 2015.
S. M. Patel, Atmar, R. L., Sahly, H. M. El, Guo, K., Hill, H., and Keitel, W. A., “Direct comparison of an inactivated subvirion influenza A virus subtype H5N1 vaccine administered by the intradermal and intramuscular routes.”, J Infect Dis, vol. 206, no. 7, pp. 1069-77, 2012.
R. L. Atmar, Opekun, A. R., Gilger, M. A., Estes, M. K., Crawford, S. E., Neill, F. H., Ramani, S., Hill, H., Ferreira, J., and Graham, D. Y., “Determination of the 50% human infectious dose for Norwalk virus.”, J Infect Dis, vol. 209, no. 7, pp. 1016-22, 2014.
R. W. Frenck, Belshe, R., Brady, R. C., Winokur, P. L., Campbell, J. D., Treanor, J., Hay, C. M., Dekker, C. L., Walter, E. B., Cate, T. R., Edwards, K. M., Hill, H., Wolff, M., Leduc, T., and Tornieporth, N., “Comparison of the immunogenicity and safety of a split-virion, inactivated, trivalent influenza vaccine (Fluzone®) administered by intradermal and intramuscular route in healthy adults.”, Vaccine, vol. 29, no. 34, pp. 5666-74, 2011.
S. E. Frey, Wald, A., Edupuganti, S., Jackson, L. A., Stapleton, J. T., Sahly, H. El, El-Kamary, S. S., Edwards, K., Keyserling, H., Winokur, P., Keitel, W., Hill, H., Goll, J. B., Anderson, E. L., Graham, I. L., Johnston, C., Mulligan, M., Rouphael, N., Atmar, R., Patel, S., Chen, W., Kotloff, K., C Creech, B., Chaplin, P., and Belshe, R. B., “Comparison of lyophilized versus liquid modified vaccinia Ankara (MVA) formulations and subcutaneous versus intradermal routes of administration in healthy vaccinia-naïve subjects.”, Vaccine, vol. 33, no. 39, pp. 5225-34, 2015.
K. L. Kotloff, Halasa, N. B., Harrison, C. J., Englund, J. A., Walter, E. B., King, J. C., C Creech, B., Healy, S. A., Dolor, R. J., Stephens, I., Edwards, K. M., Noah, D. L., Hill, H., and Wolff, M., “Clinical and immune responses to inactivated influenza A(H1N1)pdm09 vaccine in children.”, Pediatr Infect Dis J, vol. 33, no. 8, pp. 865-71, 2014.
L. M. Howard, Hoek, K. L., Goll, J. B., Samir, P., Galassie, A., Allos, T. M., Niu, X., Gordy, L. E., C Creech, B., Prasad, N., Jensen, T. L., Hill, H., Levy, S. E., Joyce, S., Link, A. J., and Edwards, K. M., “Cell-Based Systems Biology Analysis of Human AS03-Adjuvanted H5N1 Avian Influenza Vaccine Responses: A Phase I Randomized Controlled Trial.”, PLoS One, vol. 12, no. 1, p. e0167488, 2017.
I. N. Mbawuike, Atmar, R. L., Patel, S. M., Corry, D. B., Winokur, P. L., Brady, R. C., Chen, W. H., Edwards, K. M., C Creech, B., Walter, E. B., Frey, S. E., Belshe, R. B., Goll, J. B., Hill, H., and Keitel, W. A., “Cell mediated immune responses following revaccination with an influenza A/H5N1 vaccine.”, Vaccine, vol. 34, no. 4, pp. 547-554, 2016.
L. Lai, Rouphael, N., Xu, Y., Sherman, A. C., Edupuganti, S., Anderson, E. J., Lankford-Turner, P., Wang, D., Keitel, W., McNeal, M. M., Cross, K., Hill, H., Bellamy, A. R., and Mulligan, M. J., “Baseline Levels of Influenza-Specific B Cells and T Cell Responses Modulate Human Immune Responses to Swine Variant Influenza A/H3N2 Vaccine.”, Vaccines (Basel), vol. 8, no. 1, 2020.
F. M. Munoz, Weisman, L. E., Read, J. S., Siberry, G., Kotloff, K., Friedman, J., Higgins, R. D., Hill, H., Seifert, H., and Nesin, M., “Assessment of safety in newborns of mothers participating in clinical trials of vaccines administered during pregnancy.”, Clin Infect Dis, vol. 59 Suppl 7, pp. S415-27, 2014.